2026-10-14T03:24:17Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33770356 2026-09-15T03:43:08Z category_7 category_13 category_21 category_734 category_64 category_132 portal_81 item_type_3 month_year_09_2026

Additional file 1 of Comparative efficacy and safety of first, second, and third-generation EGFR tyrosine kinase inhibitors in treatment-naïve EGFR-mutant advanced non–small cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials Sumit Mahato (24911548) Shiv Mudgal (16508832) Harminder Singh (743205) Seshadri Reddy Varikasuvu (6179039) Hansraj Kumar (24911551) Jameema Thankachan (24911554) Subodh Kumar (1597564) Medicine Genetics Biotechnology Biological Sciences not elsewhere classified Cancer Infectious Diseases EGFR NSCLC Network meta-analysis TKIs Supplementary Material 1. 2026-09-14T05:00:00Z Dataset Dataset 10.6084/m9.figshare.33770356.v1 https://figshare.com/articles/dataset/Additional_file_1_of_Comparative_efficacy_and_safety_of_first_second_and_third-generation_EGFR_tyrosine_kinase_inhibitors_in_treatment-na_ve_EGFR-mutant_advanced_non_small_cell_lung_cancer_a_systematic_review_and_network_meta-analysis_of_ra/33770356 CC BY